Medtronic plc (BVMF:MDTC34)

Market Cap	688.43B
Revenue (ttm)	187.22B
Net Income (ttm)	25.66B
Shares Out	n/a
EPS (ttm)	19.88
PE Ratio	26.83
Forward PE	16.58
Dividend	5.67 (2.08%)
Ex-Dividend Date	Dec 23, 2025

Volume	8
Average Volume	12
Open	272.43
Previous Close	269.19
Day's Range	272.43 - 272.43
52-Week Range	227.76 - 277.20
Beta	0.72
RSI	62.59
Earnings Date	Feb 17, 2026

About Medtronic

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair produc...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1949
• Employees: 95,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: MDTC34

Financial Performance

In 2025, Medtronic's revenue was $33.54 billion, an increase of 3.62% compared to the previous year's $32.36 billion. Earnings were $4.66 billion, an increase of 26.82%.

Financial numbers in USD